BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26045081)

  • 1. Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.
    Flint AC; Rao VA; Chan SL; Cullen SP; Faigeles BS; Smith WS; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Johnston SC;
    Int J Stroke; 2015 Aug; 10(6):815-21. PubMed ID: 26045081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
    Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Totaled Health Risks In Vascular Events (THRIVE) score for outcome prediction in endovascular stroke treatment.
    Flint AC; Kamel H; Rao VA; Cullen SP; Faigeles BS; Smith WS
    Int J Stroke; 2014 Jan; 9(1):32-9. PubMed ID: 22928705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
    Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
    Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple variables predict miserable outcome after intravenous thrombolysis.
    Seiffge DJ; Karagiannis A; Strbian D; Gensicke H; Peters N; Bonati LH; Kotisaari K; Leppä M; Kejda-Scharler J; Tränka C; Ginsbach P; Tatlisumak T; Lyrer PA; Engelter ST
    Eur J Neurol; 2014 Feb; 21(2):185-91. PubMed ID: 24010545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The THRIVE score strongly predicts outcomes in patients treated with the Solitaire device in the SWIFT and STAR trials.
    Flint AC; Cullen SP; Rao VA; Faigeles BS; Pereira VM; Levy EI; Jovin TG; Liebeskind DS; Nogueira RG; Jahan R; Saver JL;
    Int J Stroke; 2014 Aug; 9(6):698-704. PubMed ID: 24844862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of the Totaled Health Risks in Vascular Events Score to Predict Functional Outcome and Mortality in Patients Entered into the China National Stroke Registry.
    Chen W; Liu G; Fang J; Wang Y; Song Y; Pan Y; Li H; Liu L; Wang C; Wang DZ; Zhao X; Wang Y;
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2331-7. PubMed ID: 27544868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke.
    Cappellari M; Turcato G; Forlivesi S; Bagante F; Cervellin G; Lippi G; Bonetti B; Bovi P; Toni D
    Int J Stroke; 2018 Oct; 13(7):700-706. PubMed ID: 29540109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of the DRAGON score in an elderly Spanish population: prediction of stroke prognosis after IV thrombolysis.
    Giralt-Steinhauer E; Rodríguez-Campello A; Cuadrado-Godia E; Ois Á; Jiménez-Conde J; Soriano-Tárraga C; Roquer J
    Cerebrovasc Dis; 2013; 36(2):110-4. PubMed ID: 24029547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome prediction in large vessel occlusion ischemic stroke with or without endovascular stroke treatment: THRIVE-EVT.
    Flint AC; Chan SL; Edwards NJ; Rao VA; Klingman JG; Nguyen-Huynh MN; Yan B; Mitchell PJ; Davis SM; Campbell BC; Dippel DW; Roos YB; van Zwam WH; Saver JL; Kidwell CS; Hill MD; Goyal M; Demchuk AM; Bracard S; Bendszus M; Donnan GA
    Int J Stroke; 2023 Mar; 18(3):331-337. PubMed ID: 35319310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic stroke.
    Prabhakaran S; Jovin TG; Tayal AH; Hussain MS; Nguyen TN; Sheth KN; Terry JB; Nogueira RG; Horev A; Gandhi D; Wisco D; Glenn BA; Ludwig B; Clemmons PF; Cronin CA; Tian M; Liebeskind D; Zaidat OO; Castonguay AC; Martin C; Mueller-Kronast N; English JD; Linfante I; Malisch TW; Gupta R
    Cerebrovasc Dis; 2014; 37(5):356-63. PubMed ID: 24942008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Strbian D; Meretoja A; Ahlhelm FJ; Pitkäniemi J; Lyrer P; Kaste M; Engelter S; Tatlisumak T
    Neurology; 2012 Feb; 78(6):427-32. PubMed ID: 22311929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
    Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THRIVE-c score predicts clinical outcomes in Chinese patients after thrombolysis.
    Pan Y; Peng Y; Chen W; Wang Y; Lin Y; He Y; Wang N; Wang Y
    Brain Behav; 2018 Feb; 8(2):e00927. PubMed ID: 29484275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of time to treatment on outcome in very elderly thrombolysed stroke patients.
    Frank B; Fulton RL; Lees KR;
    Int J Stroke; 2014 Jul; 9(5):591-6. PubMed ID: 24588833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial.
    Flint AC; Xiang B; Gupta R; Nogueira RG; Lutsep HL; Jovin TG; Albers GW; Liebeskind DS; Sanossian N; Smith WS;
    Stroke; 2013 Dec; 44(12):3370-5. PubMed ID: 24072003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
    Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L;
    Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.